Oct 2026· Endocrine-Related Cancer· Vol 33· 0 citations· 51 references
Medicine
TL;DR
This review article highlights some of the major paradigm shifts including i) a transition towards genotype-tailored clinical management, ii) specialized paediatric diagnostic and management protocols, iii) updated histopathological criteria, iv) the use of advanced targeted therapeutics, and v) the integration of novel predictive tools.
Abstract
Paragangliomas and phaeochromocytomas, recently reclassified to unify the disease as extra-adrenal and intra-adrenal paragangliomas, are rare neuroendocrine tumours. These tumours have an exceptionally strong hereditary component, with up to 40% of cases being driven by germline mutations in susceptibility genes; therefore, a cornerstone of modern PPGL care is the genotype-first approach, which heavily dictates initial assessment, surgical strategy, and follow-up. In recent years, the clinical landscape has evolved rapidly, leading to the publication of more than ten new consensus statements since 2022. This review article highlights some of these major paradigm shifts including i) a transition towards genotype-tailored clinical management, ii) specialized paediatric diagnostic and management protocols, iii) updated histopathological criteria, iv) the use of advanced targeted therapeutics, and v) the integration of novel predictive tools.
Optimizing the diagnosis of glomus tumors necessitates a clear distinction between two principal nosological entities. The true glomus tumor (glоmangioma) is pathognomonically associated with intense paroxysmal pain. In contrast, paraganglioma (chemodectoma) most frequently presents with compression of adjacent structu...
O. Tikhonova, E. S. Druzhinina, S. Nabiev· Neuromuscular Diseases· 0 citations
Pheochromocytomas and paragangliomas (PPGL) are rare and heterogeneous neuroendocrine tumors for which therapeutic options remain limited, particularly in the metastatic or progressive setting. Radioligand therapy (RLT) has emerged as a promising strategy, leveraging tumor-specific molecular targets to deliver cytotoxi...
S. Pacella, F. Elisei, M. V. Mattoli et al.· EJNMMI Reports· 0 citations
Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies that originates in the biliary epithelium and is anatomically classified into intrahepatic (iCCA) and extrahepatic (eCCA) subtypes. These tumors often progress silently and are associated with a poor prognosis, limiting the opportunities for timely inter...
S. Kodali, Nicole E. Rich, R. Ghobrial· Clinical Gastroenterology an...· 0 citations
This analysis systematized the approach to diagnostic algorithm for patients with head and neck paragangliomas and presented optimal algorithms for their combination for early and accurate disease detection.
A. Akhmedov, V. A. Lukshin, S. Zolotova et al.· Voprosy neirokhirurgii imeni...· 0 citations
The key role of fusion genes in driving both tumourigenesis and morphological subtypes of HACa and HA are demonstrated, and additional molecular drivers of de novo HACa are identified.
I. Ferreira, J. Billington, M. del Castillo Velasco-Herrera et al.· British Journal of Dermatolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.